Schedule 13G ownership disclosure

Ventyx Biosciences Inc

Common Stock · CUSIP: 92332V107

Event date: 2025-03-31

Filing-level shares
1,016,649.00
Percent of class
1.4%
  • BANK OF AMERICA CORP /DE/

    Shares: 1,016,649.00 · Class: 1.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000070858-25-000227
Form type
SCHEDULE 13G/A
Filer
BANK OF AMERICA CORP /DE/
CIK
CIK 70858
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub